As a researcher in the field of pain conditions and the chief medical officer of a company that manufactures prescription opioids, I recognize that we must balance the need to treat chronic pain severe enough to require opioids with ongoing efforts to address the deeply concerning opioid crisis and the impact it is having on families and communities across the country.

We at Purdue Pharma support the recent advisory by the U.S. Surgeon General emphasizing the importance of naloxone. And we recognize the efforts of other stakeholders, including pharmacies and payers, to increase access to this lifesaving intervention.